We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

197 hedge funds and large institutions have $1.92B invested in Select Medical in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 63 increasing their positions, 75 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,390% more call options, than puts

Call options by funds: $3.67M | Put options by funds: $246K

2% more capital invested

Capital invested by funds: $1.87B → $1.92B (+$46.6M)

0.18% more ownership

Funds ownership: 142.93%143.12% (+0.18%)

0% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 24

1% less funds holding

Funds holding: 198197 (-1)

16% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 75

Holders
197
Holders Change
-1
Holders Change %
-0.51%
% of All Funds
4.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
63
Reduced
75
Closed
24
Calls
$3.67M
Puts
$246K
Net Calls
+$3.42M
Net Calls Change
+$3.55M
Name Holding Trade Value Shares
Change
Change in
Stake
Nuveen
101
Nuveen
North Carolina
$688K -$795K -76,781 -53%
MLICM
102
Metropolitan Life Insurance Company (MetLife)
New York
$658K
SOADOR
103
State of Alaska Department of Revenue
Alaska
$650K +$5K +483 +0.7%
Bank of America
104
Bank of America
North Carolina
$648K -$116K -11,233 -15%
ADEF
105
Adams Diversified Equity Fund
Maryland
$648K -$48K -4,640 -7%
Renaissance Technologies
106
Renaissance Technologies
New York
$648K +$217K +20,973 +47%
Russell Investments Group
107
Russell Investments Group
United Kingdom
$646K -$319K -30,799 -32%
GC
108
Guggenheim Capital
Illinois
$602K +$259K +25,055 +70%
GCP
109
GSA Capital Partners
United Kingdom
$591K -$545K -52,655 -47%
MSA
110
Mason Street Advisors
Wisconsin
$590K +$21.5K +2,077 +4%
FAF
111
Första AP-fonden
Sweden
$570K -$204K -19,674 -25%
IRC
112
Investors Research Corp
Georgia
$556K -$19.2K -1,856 -3%
SGH
113
Sivik Global Healthcare
Connecticut
$552K +$576K +55,680 New
JMPWA
114
JP Morgan Private Wealth Advisors
California
$532K +$555K +53,631 New
FIM
115
Freedom Investment Management
Connecticut
$526K -$15.2K -1,472 -3%
TRSOTSOK
116
Teachers Retirement System of the State of Kentucky
Kentucky
$524K -$26.9K -2,598 -5%
Citigroup
117
Citigroup
New York
$480K -$151K -14,598 -23%
COPPSERS
118
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$476K +$60.9K +5,882 +14%
ERSOT
119
Employees Retirement System of Texas
Texas
$460K +$480K +46,400 New
PIA
120
Piedmont Investment Advisors
North Carolina
$459K -$1.1K -106 -0.2%
Brown Advisory
121
Brown Advisory
Maryland
$445K +$465K +44,886 New
Tudor Investment Corp
122
Tudor Investment Corp
Connecticut
$430K +$449K +43,386 New
AG
123
Aperio Group
California
$414K -$3.39K -327 -0.8%
PTC
124
Petrus Trust Company
Texas
$403K -$149K -14,411 -26%
CWM
125
Cornerstone Wealth Management
Missouri
$400K -$1.54K -149 -1%

SEM Hedge Fund Activity: Q3 2018 in Review

197 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q3 2018, worth a combined $1.92B — up 2.5% from $1.87B a quarter earlier.

Fund positioning in SEM was balanced in Q3 2018: 24 funds opened new positions, 24 closed out, 63 added to existing stakes and 75 trimmed.

The largest buyer was TimesSquare Capital Management, opening a new position worth an estimated $33.1M. The largest seller was OrbiMed, cutting an estimated $77.6M.

  • 197 institutional investors held Select Medical (SEM) as of Q3 2018, down from 198 in Q2 2018.
  • Funds reported $1.92B of Select Medical stock for Q3 2018, up 2.5% quarter-over-quarter.
  • 24 funds opened new Select Medical positions in Q3 2018 and 24 closed out, a net change of 0 holders.
  • The largest Select Medical buyer in Q3 2018 was TimesSquare Capital Management, an estimated $33.1M added.
  • The largest Select Medical seller in Q3 2018 was OrbiMed, an estimated $77.6M sold.

Based on aggregated 13F filings for Q3 2018.